Volume 9, Number 2—February 2003
Annual Mycobacterium tuberculosis Infection Risk and Interpretation of Clustering Statistics
- van Soolingen D, Borgdorff MW, de Haas PE, Sebek MM, Veen J, Dessens M, Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997. J Infect Dis. 1999;180:726–36.
- Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med. 1994;330:1703–9.
- Bauer J, Yang Z, Poulsen S, Andersen AB. Results from 5 years of nationwide DNA fingerprinting of Mycobacterium tuberculosis complex isolates in a country with a low incidence of M. tuberculosis infection. J Clin Microbiol. 1998;36:305–8.
- Styblo K, Meijer J, Sutherland I. The transmission of tubercle bacilli: its trend in a human population. Bull Int Union Tuberc. 1969;42:5–104.
- de Boer AS, Borgdorff MW, de Haas PEW, Nagelkerke NJ, van Embden JD, van Soolingen D. Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates. J Infect Dis. 1999;180:1238–44.
- Vynnycky E, Nagelkerke N, Borgdorff MW, van Soolingen D, van Embden JDA, Fine PEM. The effect of age and study duration on the relationship between ‘clustering’ of DNA fingerprint patterns and the proportion of tuberculosis disease attributable to recent transmission. Epidemiol Infect. 2001;126:43–62.
- Holm J. Development from tuberculous infection to tuberculous disease. The Hague, the Netherlands: Royal Dutch Tuberculosis Assocation (KNCV); 1969.
- Sutherland I, Švandová E, Radhakrishna SE. The development of clinical tuberculosis following infection with tubercle bacilli. Tubercle. 1982;63:255–68.
- Vynnycky E, Fine PEM. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect. 1997;119:183–201.
- Sutherland I, Bleiker MA, Meijer J, Styblo K. The risk of infection in the Netherlands from 1967 to 1979. Tubercle. 1983;64:241–53.
- Fine PEM, Bruce J, Ponnighaus JM, Nkhosa P, Harawa A, Vynnycky E. Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis. 1999;3:962–75.
- van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med. 1999;341:1174–9.
- Sutherland I. The ten-year incidence of clinical tuberculosis following “conversion” in 2,550 individuals aged 14 to 19 years. The Hague, the Netherlands: Royal Dutch Tuberculosis Association (KNCV); 1968.
- Glynn JR, Bauer J, de Boer AS, Borgdorff MW, Fine PEM, Godfrey-Faussett P, Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Int J Tuberc Lung Dis. 1999;3:1055–60.
- Yeh RW, Ponce de Leon A, Agasino CB, Hahn JA, Daley CL, Hopewell PC, Stability of Mycobacterium tuberculosis DNA genotypes. J Infect Dis. 1998;177:1107–11.
- Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994;330:1710–6.
- Glynn JR. Resurgence of tuberculosis and the impact of HIV infection. Br Med Bull. 1998;54:579–93.
- Glynn JR, Warndorff DK, Fine PEM, Msiska GK, Munthali MM, Ponnighaus JM. The impact of HIV on morbidity and mortality from tuberculosis in sub-Saharan Africa: a study in rural Malawi and review of the literature. Health Transit Rev. 1997; 75–87.
- ten Asbroek AH, Borgdorff MW, Nagelkerke NJ, Sebek MM, Deville W, van Embden JD, Estimation of serial interval and incubation period of tuberculosis using DNA fingerprinting. Int J Tuberc Lung Dis. 1999;3:414–20.
Page created: June 08, 2011
Page updated: June 08, 2011
Page reviewed: June 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.